Key opinion leaders highlight the MS treatment landscape. Ryan Haumschild, PharmD, MS, MBA: Now that we’ve talked about the background of multiple sclerosis [MS] in detail, I think it’s important for ...

Neurologists have found in a recent study that common drugs to treat multiple sclerosis lead to modest health benefits but very high costs, according to a news release from Kirkland, Wash.-based ...

Multiple sclerosis (MS) treatment could be on the brink of a significant breakthrough thanks to innovative research by Immunic Therapeutics. Speaking to Fierce Pharma, CEO Daniel Vitt shares insights ...

Scientists are testing a drug that may offer hope for reversing nerve damage in MS. MANICO/Getty Images When immune cells attack the myelin sheath, this causes inflammation and interrupts the passage ...

Advances in diagnostics and disease-modifying therapies have significantly expanded treatment options for MS over the past 2 ...

What causes gray matter loss in Multiple Sclerosis? New research identifies DNA damage in CUX2 neurons as a primary driver of MS progression.

Scientists have used AI to identify two novel subtypes of multiple sclerosis (MS), which could offer new, targeted treatments for patients. MS affects around 2.8 million people across the world. It’s ...

BTK inhibitor implementation for MS treatment is explored. Ryan Haumschild, PharmD, MS, MBA: Now if we could, let’s discuss the emerging role of Bruton tyrosine kinase inhibitors [BTKis] in multiple ...

"The observed differential effects of high-efficacy disease-modifying agents across sexes underscore the importance of sex-specific considerations in making treatment decisions to personalize care in ...

Smoldering-associated worsening (SAW) of multiple sclerosis (MS) deserves a broader, more comprehensive approach to diagnosis, treatment, and research that goes beyond neurologists’ understanding of ...

The ACP received funding to help interpret research and support decisions about MS treatments for older adults with MS.

Share on Pinterest Scientists are testing a drug that may offer hope for reversing nerve damage in MS. MANICO/Getty Images Multiple sclerosis (MS) is a chronic disease of the nervous system that can ...